RATIONALE: The heterotypic interactions of endothelial cells and mural cells (smooth muscle cells or pericytes) are crucial for assembly, maturation, and subsequent function of blood vessels. Yet, the molecular mechanisms underlying their association have not been fully defined. OBJECTIVE: Our previous in vitro studies indicated that Notch3, which is expressed in mural cells, mediates these cell-cell interactions. To assess the significance of Notch3 on blood vessel formation in vivo, we investigated its role in retinal angiogenesis. METHODS AND RESULTS: We show that Notch3-deficient mice exhibit reduced retinal vascularization, with diminished sprouting and vascular branching. Moreover, Notch3 deletion impairs mural cell investment, resulting in progressive loss of vessel coverage. In an oxygen-induced retinopathy model, we demonstrate that Notch3 is induced in hypoxia and interestingly, pathological neovascularization is decreased in retinas of Notch3-null mice. Analysis of oxygen-induced retinopathy mediators revealed that angiopoietin-2 expression is significantly reduced in the absence of Notch3. Furthermore, in vitro experiments showed that Notch3 is sufficient for angiopoietin-2 induction, and this expression is additionally enhanced in the presence of hypoxia-inducible factor 1α. CONCLUSIONS: These results provide compelling evidence that Notch3 is important for the investment of mural cells and is a critical regulator of developmental and pathological blood vessel formation.
RATIONALE: The heterotypic interactions of endothelial cells and mural cells (smooth muscle cells or pericytes) are crucial for assembly, maturation, and subsequent function of blood vessels. Yet, the molecular mechanisms underlying their association have not been fully defined. OBJECTIVE: Our previous in vitro studies indicated that Notch3, which is expressed in mural cells, mediates these cell-cell interactions. To assess the significance of Notch3 on blood vessel formation in vivo, we investigated its role in retinal angiogenesis. METHODS AND RESULTS: We show that Notch3-deficient mice exhibit reduced retinal vascularization, with diminished sprouting and vascular branching. Moreover, Notch3 deletion impairs mural cell investment, resulting in progressive loss of vessel coverage. In an oxygen-induced retinopathy model, we demonstrate that Notch3 is induced in hypoxia and interestingly, pathological neovascularization is decreased in retinas of Notch3-null mice. Analysis of oxygen-induced retinopathy mediators revealed that angiopoietin-2 expression is significantly reduced in the absence of Notch3. Furthermore, in vitro experiments showed that Notch3 is sufficient for angiopoietin-2 induction, and this expression is additionally enhanced in the presence of hypoxia-inducible factor 1α. CONCLUSIONS: These results provide compelling evidence that Notch3 is important for the investment of mural cells and is a critical regulator of developmental and pathological blood vessel formation.
Authors: Valérie Domenga; Peggy Fardoux; Pierre Lacombe; Marie Monet; Jacqueline Maciazek; Luke T Krebs; Bernard Klonjkowski; Eliane Berrou; Matthias Mericskay; Zhen Li; Elisabeth Tournier-Lasserve; Thomas Gridley; Anne Joutel Journal: Genes Dev Date: 2004-11-15 Impact factor: 11.361
Authors: Kathleen M Loomes; Darren B Taichman; Curtis L Glover; Patrick T Williams; Jonathan E Markowitz; David A Piccoli; H Scott Baldwin; Rebecca J Oakey Journal: Am J Med Genet Date: 2002-10-01
Authors: E J Belin de Chantemèle; K Retailleau; F Pinaud; E Vessières; A Bocquet; A L Guihot; B Lemaire; V Domenga; C Baufreton; L Loufrani; A Joutel; D Henrion Journal: Arterioscler Thromb Vasc Biol Date: 2008-09-25 Impact factor: 8.311
Authors: Catherine Sweeney; David Morrow; Yvonne A Birney; Seamus Coyle; Colm Hennessy; Agnieszka Scheller; Philip M Cummins; Dermot Walls; Eileen M Redmond; Paul A Cahill Journal: FASEB J Date: 2004-07-09 Impact factor: 5.191
Authors: Joseph F Arboleda-Velasquez; Zhipeng Zhou; Hwa Kyoung Shin; Angeliki Louvi; Hyung-Hwan Kim; Sean I Savitz; James K Liao; Salvatore Salomone; Cenk Ayata; Michael A Moskowitz; Spyros Artavanis-Tsakonas Journal: Proc Natl Acad Sci U S A Date: 2008-03-17 Impact factor: 11.205
Authors: L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore Journal: Invest Ophthalmol Vis Sci Date: 1994-01 Impact factor: 4.799
Authors: Hossein Ameri; Hua Liu; Rong Liu; Yonju Ha; Adriana A Paulucci-Holthauzen; Shuqun Hu; Massoud Motamedi; Bernard F Godley; Ronald G Tilton; Wenbo Zhang Journal: Invest Ophthalmol Vis Sci Date: 2014-02-10 Impact factor: 4.799
Authors: Alaina M Reagan; Xiaowu Gu; Sijalu Paudel; Nicole M Ashpole; Michelle Zalles; William E Sonntag; Zoltan Ungvari; Anna Csiszar; Laura Otalora; Willard M Freeman; Michael B Stout; Michael H Elliott Journal: Neurobiol Aging Date: 2018-07-10 Impact factor: 4.673
Authors: Anna Lehman; Anna-Barbara Stittrich; Gustavo Glusman; Zheyuan Zong; Hong Li; Patrice Eydoux; Christof Senger; Christopher Lyons; Jared C Roach; Millan Patel Journal: Am J Med Genet A Date: 2014-08-04 Impact factor: 2.802
Authors: Koji Ando; Weili Wang; Di Peng; Ayano Chiba; Anne K Lagendijk; Lindsey Barske; J Gage Crump; Didier Y R Stainier; Urban Lendahl; Katarzyna Koltowska; Benjamin M Hogan; Shigetomo Fukuhara; Naoki Mochizuki; Christer Betsholtz Journal: Development Date: 2019-01-25 Impact factor: 6.868